retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial Explained: The Changing Medicine retatrutide triple agonist gip glp-1

OA synovitis directly contributes to several clinical signs and symptoms, including joint swelling and effusion, and reflects the structural progression of the disease 8,9

Walking lunges: 3 sets of 12 per leg

Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotics acetate and lactate which feed bacteria such as Akkermansia and Butyricum, promoting an ecosystem in the gut that supports a healthy gut lining and naturally boosts GLP-1. Suggested Use: Adults take 1 capsule daily with food, or as recommended by your healthcare professional

GLP-1 analogs demonstrated efficacy in cases refractory to other treatment modalities, often in cases of patients with obesity who would experience additional benefits from starting therapy